We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+0.8%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$5.19B
AUM Growth
+$1.66B
Cap. Flow
+$1.67B
Cap. Flow %
32.19%
Top 10 Hldgs %
18.45%
Holding
2,107
New
937
Increased
472
Reduced
322
Closed
350

Sector Composition

Rank Sector Weight
1 Technology 7.63%
2 Healthcare 7.06%
3 Consumer Discretionary 6.95%
4 Financials 5.49%
5 Industrials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARRY
1651
DELISTED
Array Biopharma Inc
ARRY
$113K ﹤0.01%
+15,729
New +$116K
ADNC
1652
DELISTED
AUDIENCE INC COM STK (DE)
ADNC
$111K ﹤0.01%
+22,700
New +$113K
KIN
1653
DELISTED
Kindred Biosciences, Inc.
KIN
$110K ﹤0.01%
+16,150
New +$115K
LBMH
1654
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
$110K ﹤0.01%
+48,550
New +$141K
FCF icon
1655
First Commonwealth Financial
FCF
$2.12B
$109K ﹤0.01%
+11,400
New +$105K
PGH
1656
DELISTED
Pengrowth Energy Corporation
PGH
$109K ﹤0.01%
+43,800
New +$129K
SALM
1657
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$106K ﹤0.01%
+16,800
New +$91.1K
BONT
1658
DELISTED
Bon-Ton Stores Inc/The
BONT
$104K ﹤0.01%
+22,500
New +$143K
ANR
1659
DELISTED
Alpha Natural Resources Inc
ANR
$104K ﹤0.01%
343,293
+109,831
+47% +$75.6K
PVG
1660
DELISTED
PRETIUM RESOURCES INC.
PVG
$103K ﹤0.01%
+19,077
New +$111K
ATNM icon
1661
Actinium Pharmaceuticals
ATNM
$27M
$102K ﹤0.01%
+1,285
New +$110K
MNI
1662
DELISTED
The McClatchy Company Class A Common Stock
MNI
$102K ﹤0.01%
+9,415
New +$130K
CDE icon
1663
Coeur Mining
CDE
$15.6B
$101K ﹤0.01%
+17,700
New +$97K
HL icon
1664
Hecla Mining
HL
$10.2B
$101K ﹤0.01%
+38,400
New +$118K
FLNA
1665
Filana Therapeutics
FLNA
$43M
$101K ﹤0.01%
+8,379
New +$115K
AREX
1666
DELISTED
Approach Resources Inc.
AREX
$100K ﹤0.01%
+14,600
New +$110K
NBSE
1667
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$99K ﹤0.01%
+99
New +$107K
RBCN
1668
DELISTED
Rubicon Technology, Inc.
RBCN
$98K ﹤0.01%
+4,030
New +$131K
PSTV icon
1669
Plus Therapeutics
PSTV
$26.4M
0
CBB
1670
DELISTED
Cincinnati Bell Inc.
CBB
$96K ﹤0.01%
+5,000
New +$91.3K
MHR
1671
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
$96K ﹤0.01%
+51,452
New +$102K
IRC
1672
DELISTED
INLAND REAL ESTATE CORP
IRC
$95K ﹤0.01%
+10,100
New +$103K
ASX icon
1673
ASE Group
ASX
$80.8B
$94K ﹤0.01%
+14,200
New +$98.9K
UNIS
1674
DELISTED
Unilife Corporation
UNIS
$92K ﹤0.01%
+4,280
New +$130K
UCP
1675
DELISTED
UCP, Inc.
UCP
$91K ﹤0.01%
+12,050
New +$101K

Similar funds

Paloma Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Paloma Partners held 2,107 positions worth $5.19B, up 47% from $3.53B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Paloma Partners deployed $1.67B of net new capital in Q2 2015, opening 937 new positions and adding to 472 existing holdings. Its largest new stake was Hilton Worldwide: 331,558 shares worth $27.4M.

By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Booking.com, an estimated $22.4M trimmed.

  • Paloma Partners's largest Q2 2015 buy was Hilton Worldwide: 331,558 shares worth $27.4M.
  • Paloma Partners added most to DRESSER-RAND GROUP INC in Q2 2015, an estimated $84.6M increase.
  • Paloma Partners's biggest Q2 2015 reduction was Booking.com, cutting an estimated $22.4M.
  • Paloma Partners fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $43.2M.
  • Paloma Partners's ten largest holdings make up 18% of its $5.19B portfolio in Q2 2015.
  • Paloma Partners opened 937 new positions and closed 350 in Q2 2015.
  • Paloma Partners's portfolio value rose 47% quarter-over-quarter to $5.19B.

Based on Paloma Partners's 13F filing for Q2 2015, filed 14 Aug 2015.